Xenetic Biosciences
XBIO
Xenetic Biosciences (XBIO) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Neutral | — | Apr 9, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | — | Mar 20, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | — | Dec 5, 2024 |
| HC Wainwright & Co. | Maintained | Neutral | — | Nov 22, 2024 |
| HC Wainwright & Co. | Maintained | Neutral | — | Aug 20, 2024 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | — | May 16, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Apr 11, 2023 |
Frequently asked questions
What is the latest analyst rating on XBIO?
On Apr 9, 2025, HC Wainwright & Co. maintained Xenetic Biosciences at Neutral.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.